Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of

HyeSook Youn1,2, Beomseok Son3, Wanyeon Kim1,2

  • 1Department of Biological Sciences, Pusan National University, Busan, 609-735, Republic of Korea.

Insights

Ionizing radiation (IR) can trigger non-small cell lung cancer (NSCLC) metastasis by dissociating the MIF-rpS3 complex, activating the NF-κB pathway. This molecular event promotes tumor cell inflammation and spread, hindering radiotherapy effectiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Non-small cell lung cancer (NSCLC) frequently relapses and metastasizes during radiotherapy, representing a significant clinical challenge.
  • Macrophage migration inhibitory factor (MIF) is highly expressed in lung cancer and implicated in metastasis.

Purpose of the Study:

  • To investigate the role of MIF in regulating NSCLC metastasis following ionizing radiation (IR).
  • To elucidate the molecular mechanisms linking MIF, ribosomal protein S3 (rpS3), and the NF-κB pathway in IR-induced metastasis.

Main Methods:

  • Investigated the interaction between MIF and rpS3 in NSCLC cell lines (A549, NCI-H358) under unirradiated and irradiated conditions.
  • Assessed NF-κB pathway activation, pro-inflammatory cytokine secretion, and epithelial-mesenchymal transition (EMT) marker expression post-IR.
  • Utilized in vivo xenograft models to confirm the impact of MIF-rpS3 complex dissociation on tumor metastasis.

Main Results:

  • IR induced dissociation of the MIF-rpS3 complex in NSCLC cells.
  • Dissociation activated the NF-κB pathway, leading to transactivation of target genes and increased secretion of pro-inflammatory cytokines.
  • IR-induced dissociation modulated EMT markers and promoted tumor metastasis in vivo.

Conclusions:

  • Dissociation of the MIF-rpS3 complex is a critical event following IR exposure in NSCLC.
  • This dissociation activates the NF-κB pathway, driving IR-induced metastatic conversion of NSCLC.
  • Targeting the MIF-rpS3 complex or NF-κB pathway may offer strategies to inhibit radiation-induced metastasis in NSCLC.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K